Manipal Health Enterprises is likely to launch its IPO as early as next month, targeting a valuation of around $10 billion. Backed by Temas...

Private sector banks are attracting investors with robust credit growth and stable asset quality. Experts anticipate a rate cycle shift, bo...

A US-Iran peace framework has sparked a sharp rally in Indian markets, sending crude oil prices lower, strengthening the rupee and promptin...

Kotak Mutual Fund has launched its maiden Specialised Investment Fund (SIF), the Kotak Infinity Hybrid Long-Short Fund, marking its entry i...

Traders are piling into bullish derivative bets on banks, reversing bearish positions, as RBI's foreign currency borrowing measures boost l...

Uday Kotak described SpaceX’s blockbuster IPO as a test for capitalism, questioning whether investors are backing humanity’s future or fuel...

Lenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.

Indian banks are launching a global campaign to attract over $50 billion in deposits from the diaspora. This initiative aims to strengthen ...

The Indian rupee experienced a robust uptick against the dollar on Friday, sparked by newfound optimism regarding peace talks between the U...

Bank stocks saw a significant jump on Friday, propelling the Nifty Bank index to a one-month peak. This surge followed news of a potential ...

Lenskart Solutions saw significant stake activity as marquee investors bought Rs 1,960 crore in a block deal, with Platinum Jasmine A 2018 ...

ADIA-backed Platinum Jasmine A 2018 Trust sold a 2.3% stake in Lenskart through a Rs 1,960 crore block deal. The transaction attracted stro...

Eyewear retailer Lenskart Solutions experienced a significant block deal valued at Rs 1,862 crore. Abu Dhabi Investment Authority, through ...

Abu Dhabi Investment Authority is set to divest a 2.3% stake in Lenskart for approximately Rs 1,944 crore via a block deal. This follows So...

Indian stock markets surged for a second consecutive session, with Sensex and Nifty crossing significant milestones. This resilience occurr...

Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...